Clinical Trial Update: Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer [NA]

View source ↗

Summary

Clinical trial update reports completed results from a study evaluating the PRO Onc Assay as a method to determine HER2 status in patients with metastatic breas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2016-01-29